Biotech Values

[DewDiligence]

PLX—Their cheap/high capacity technology could be a plus too though to me that isn't enough by itself unless their goal is to be a high-end "generics" play.

I think it’s important to distinguish between biosimilars and biogenerics. A low-cost manufacturing platform helps with the former, but it does not necessarily help with the latter.